Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia

BACKGROUND: The efficacy of the recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV) against virologically-confirmed dengue (VCD) has been documented in a phase 3 trial in Latin America (CYD15, NCT01374516). This is a descriptive secondary analysis of the efficacy and safety of CYD-TD...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynales, Humberto, Carrasquilla, Gabriel, Zambrano, Betzana, Cortés S, Margarita, Machabert, Tifany, Jing, Jin, Pallardy, Sophie, Haney, Owen, Faccini, Martha, Quintero, Juliana, Noriega, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Williams & Wilkins 2020
Materias:
Vaccine Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182239/
https://www.ncbi.nlm.nih.gov/pubmed/32040014
http://dx.doi.org/10.1097/INF.0000000000002580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182239/
https://www.ncbi.nlm.nih.gov/pubmed/32040014
http://dx.doi.org/10.1097/INF.0000000000002580

Ejemplares similares